10.17.23 -- From Chips To Genes: The New Era Of Animal Models Transforming Drug Testing And Research

To meet ambitious orphan drug development timelines, CDMOs must be able to scale quickly to progress from early clinical development to validation and commercial launch.

This paper presents three approaches to address poor solubility in organic solvents for spray drying, as well as case studies outlining their successful application during development.

Choosing the right tag is essential to getting the purity, solubility, and protein quality your application needs. Learn how to prepare a recombinant protein in the quantity and quality you need.

Review a modeling approach employing artificial neural networks (ANNs) using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

By reducing drug particle size, nanoforming opens up new opportunities — from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies.